 |
 |
|
|
|
| Zinc methionine |
 |
| Zinc methionine |
 |
Zinc methionine
Zinc methionine
This product is chelated by DL-methionine and zinc sulphate, has the following characteristic:
1. Resulting from the reaction of a mole of zinc ion to two moles of methionine, with high chelate percentage, completely electric neutrality and the greatest stability.
2. The bioavailability is high, and the nutrition effect of zinc will be better.
3. Don't be affected by pH value, inorganic ions and organic macromolecules in digestive tract.
[Guarantee value of component analysis]
Item Ⅰ Ⅱ
Zinc methionine [(C5H10O2NS) 2Zn] ≥50.0% ≥95.2%
Zinc（ Zn ） 10.0±1.0% ≥17.2%
Methionine (C5H11O2NS) ≥41.0% ≥78.0%
Chelate percentage ≥90.0% ≥95.0%
【Recommended dosage】
Add 200g-300g of Ⅰzinc methionine per metric ton of compound feed.
Add 100g-200g of Ⅱ high purity zinc methionine per metric ton of compound feed.
【Packaging】
25kg / bag (PP woven bag with PE bag inside) for Ⅰzinc methionine
15kg / bag (PP woven bag with PE bag inside) for Ⅱ high purity zinc methionine
|
 |
Zinc methionine
Zinc methionine
This product is chelated by DL-methionine and zinc sulphate, has the following characteristic:
1. Resulting from the reaction of a mole of zinc ion to two moles of methionine, with high chelate percentage, completely electric neutrality and the greatest stability.
2. The bioavailability is high, and the nutrition effect of zinc will be better.
3. Don't be affected by pH value, inorganic ions and organic macromolecules in digestive tract.
[Guarantee value of component analysis]
Item Ⅰ Ⅱ
Zinc methionine [(C5H10O2NS) 2Zn] ≥50.0% ≥95.2%
Zinc（ Zn ） 10.0±1.0% ≥17.2%
Methionine (C5H11O2NS) ≥41.0% ≥78.0%
Chelate percentage ≥90.0% ≥95.0%
【Recommended dosage】
Add 200g-300g of Ⅰzinc methionine per metric ton of compound feed.
Add 100g-200g of Ⅱ high purity zinc methionine per metric ton of compound feed.
【Packaging】
25kg / bag (PP woven bag with PE bag inside) for Ⅰzinc methionine
15kg / bag (PP woven bag with PE bag inside) for Ⅱ high purity zinc methionine
|
|
|
|
|
|
